PTCB Study Guide: Comprehensive Cardiovascular, CNS, and Respiratory Medications

General Information and Steroid Reference

This study guide pertains to the Pharmacy Technician Certification Board (PTCB) exam focus areas of Cardiovascular, Central Nervous System (CNS), and Respiratory medications. The document includes a timestamp indicator of $4:32$ and a reference to steroids labeled as D. The primary objective of these notes is to cover the pharmacological categories, specific examples, clinical uses, side effects, and critical interactions associated with these drug classes.

Cardiovascular Medications: ACE Inhibitors and Angiotensin Receptor Blockers (ARBs)

Angiotensin-Converting Enzyme (ACE) Inhibitors are identified by the pharmacological suffix $\text{-pril}$. Specific medications in this class include Lisinopril, Enalapril, and Benazepril. These drugs are primarily utilized for the management of hypertension (high blood pressure) and heart failure. Patients taking ACE Inhibitors may experience side effects such as a persistent dry cough, hyperkalemia (elevated potassium levels), and angioedema (severe swelling under the skin). Clinically significant interactions occur with potassium supplements, potassium-sparing diuretics, and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

Angiotensin Receptor Blockers (ARBs) are distinguished by the pharmacological suffix $\text{-sartan}$. Representative drugs in this category include Losartan, Valsartan, and Olmesartan. These medications are used for the treatment of hypertension. Common side effects associated with ARBs include hyperkalemia and dizziness. Their interactions are similar to ACE Inhibitors, specifically involving potassium supplements and potassium-sparing diuretics.

Beta Blockers, Calcium Channel Blockers, and Diuretics

Beta Blockers utilize the suffix $\text{-lol}$. Examples of medications in this class are Metoprolol, Atenolol, Propranolol, and Carvedilol. Their clinical applications range from treating hypertension and heart failure to managing arrhythmias. Side effects commonly noted include bradycardia (slow heart rate) and fatigue. Important interactions involve Verapamil, Diltiazem, and insulin. Notably, beta blockers may mask the symptoms of hypoglycemia (low blood sugar), which is a critical consideration for diabetic patients.

Calcium Channel Blockers (CCBs) include medications such as Amlodipine, Diltiazem, and Verapamil. These are used primarily for hypertension and angina (chest pain). Side effects include edema (swelling) and, specifically in the case of Verapamil, constipation. Significant interactions are observed with grapefruit juice and beta blockers. Diuretics are another major cardiovascular class including Hydrochlorothiazide (a thiazide diuretic), Furosemide (a loop diuretic), and Spironolactone (a potassium-sparing diuretic). These medications interact with Digoxin, lithium, and various potassium products.

Cholesterol Management: Statins and Fibrates

Statins are the primary agents for managing high cholesterol and are identified by the suffix $\text{-statin}$. Key examples include Atorvastatin, Rosuvastatin, and Simvastatin. Potential side effects include muscle pain (myalgia) and liver toxicity. Interactions are common with grapefruit juice, particularly for Simvastatin and Atorvastatin, as well as with fibrates (another class of lipid-lowering drugs).

Central Nervous System (CNS) Medications: Antidepressants (SSRIs and SNRIs)

Selective Serotonin Reuptake Inhibitors (SSRIs) include Sertraline, Fluoxetine, Escitalopram, and Citalopram. These agents are used to treat depression and anxiety. They carry a risk of serotonin syndrome, especially when interacting with Monoamine Oxidase Inhibitors (MAOIs), St. John's Wort, or tramadol. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) include Duloxetine, Venlafaxine, and Desvenlafaxine. Their clinical uses include depression, anxiety, and nerve pain. Significant interactions involve MAOIs and other serotonergic medications.

Anxiolytics, Sedatives, and Anticonvulsant Medications

Benzodiazepines are identified by the suffixes $\text{-pam}$ and $\text{-lam}$. Medications in this class include Alprazolam, Lorazepam, Diazepam, and Clonazepam. They are prescribed for anxiety, seizures, and insomnia. Notable side effects include sedation and the potential for dependence. They interact dangerously with alcohol, opioids, and other sleep medications. Anticonvulsants include Gabapentin, Pregabalin, Levetiracetam, and Lamotrigine. These are used for seizures and neuropathy. They interact with CNS depressants, and specifically, Lamotrigine has a known interaction with valproic acid.

Respiratory Medications: Rescue Therapies and Maintenance Corticosteroids

Beta-$2$ Agonists, such as Albuterol and Levalbuterol, serve as rescue treatments for Asthma and Chronic Obstructive Pulmonary Disease (COPD). Their side effects include tremor and tachycardia (rapid heart rate). Beta blockers may reduce the effectiveness of these rescue inhalers. For maintenance treatment, Inhaled Corticosteroids like Fluticasone, Budesonide, and Beclomethasone are used. A common side effect is oral thrush (candidiasis), so patients are counseled to rinse their mouth after use.

Antihistamines and Combination Inhalers for Chronic Obstructive Pulmonary Disease (COPD)

Antihistamines are used for allergy management and include Cetirizine, Loratadine, Fexofenadine, and Diphenhydramine. Drowsiness is a frequent side effect, particularly with Diphenhydramine. These interact with alcohol and other sedatives. For COPD, several combination inhalers are frequently tested for the PTCB, including Advair (a combination of Fluticasone and Salmeterol), Symbicort (a combination of Budesonide and Formoterol), and Trelegy Ellipta. Mastery of both brand and generic names is required for these combination products.

Critical Drug-Drug and Drug-Food Interactions

Several life-threatening interactions are emphasized for exam preparation: $1$. Benzodiazepines combined with Opioids can lead to fatal respiratory depression. $2$. Benzodiazepines combined with alcohol result in excessive sedation. $3$. SSRIs or SNRIs combined with MAOIs can cause serotonin syndrome. $4$. Statins combined with Gemfibrozil (a fibrate) may result in severe muscle toxicity. $5$. ACE Inhibitors or ARBs combined with potassium products can lead to dangerous levels of hyperkalemia. $6$. Beta blockers have the potential to mask the physiological symptoms of hypoglycemia. $7$. Verapamil or Diltiazem combined with beta blockers can lead to severe bradycardia. $8$. Grapefruit juice serves as a significant dietary interaction for many statins and calcium channel blockers.

PTCB Preparation: Pharmacological Suffixes and High-Yield Medications

To aid in memorization, follow these suffix clusters: $\text{-pril}$ for ACE Inhibitors, $\text{-sartan}$ for ARBs, $\text{-lol}$ for Beta blockers, $\text{-statin}$ for cholesterol medications, and $\text{-pam}$ or $\text{-lam}$ for benzodiazepines. High-yield medications most frequently tested on the PTCB include Lisinopril, Losartan, Metoprolol, Amlodipine, Hydrochlorothiazide, Furosemide, Atorvastatin, Sertraline, Fluoxetine, Alprazolam, Gabapentin, Albuterol, Fluticasone, Cetirizine, and Diphenhydramine.